While we had observed elevated TGFβ‐signaling specifically in the MSS subtype, analysis of individual patients revealed that this pathway clustered specifically with MSS tumors that had reduced activation of JAK/STAT, MAPK, and EGFR signaling (Fig. S6). This evidence concerns the gene EGFR and Marinesco-Sjogren syndrome.